Retinal Age as Disease Biomarker - Scorecard - MDSpire

Retinal Age as Disease Biomarker

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

  • May 27, 2026

  • 3 min

Share

Clinical Scorecard: Retinal Age as Disease Biomarker

At a Glance

CategoryDetail
ConditionBiological aging and systemic disease risk assessment
Key MechanismsAI-predicted retinal age compared to chronological age (retinal age gap)
Target PopulationIndividuals undergoing retinal imaging, particularly those at risk for systemic diseases
Care SettingRoutine clinical workflows utilizing fundus photography

Key Highlights

  • AI model trained on over 50,000 fundus images from 27,000 healthy individuals
  • Achieved mean absolute error of 2.78 years in internal validation
  • Retinal age gaps linked to diabetes, cardiac disease, and stroke history
  • Focus on optic disc, macula, and major vascular arcades for predictions

Guideline-Based Recommendations

Diagnosis

  • Utilize retinal imaging to estimate biological aging and assess disease risk

Management

  • Flag patients with high retinal age gaps for further cardiovascular or metabolic evaluation

Monitoring & Follow-up

  • Consider retinal age as a metric in routine screenings for systemic health

Risks

  • Performance may decline in diverse datasets and is influenced by image quality

Patient & Prescribing Data

Predominantly Asian individuals

Integration of AI-based retinal age outputs into existing screening programs

Clinical Best Practices

  • Incorporate AI-driven retinal age assessments into routine eye care
  • Ensure high-quality fundus images to improve accuracy of predictions

Related Resources & Content

Original Source(s)

Retinal Age as Disease Biomarker

  • May 27, 2026

Related Content

Oculomics: Beyond the Buzzword

Joseph J. Pizzimenti, OD, FAAO, FORS, discusses the capabilities of oculomics in retina and neuro-ophthalmology,

AI Tool May Cut Macular Edema Referrals

An artificial intelligence–based optical coherence tomography pathway met noninferiority criteria for false-positive diabetic macular edema referrals and was associated with fewer referral decisions in a randomized clinical trial.

Myopia Severity Tied to Pediatric Retinal Pathology

Routine dilated examinations identified peripheral retinal abnormalities across refractive groups, with higher pathology rates among patients with at least 3.00 D of myopia